MSB 7.69% $1.19 mesoblast limited

Ann: Mesoblast Partners with BMT CTN on Adult SR-aGVHD Trial, page-149

  1. 30,316 Posts.
    lightbulb Created with Sketch. 1835
    FDA is ignoring the fact they don't have any other alternative to this treatment.

    Exactly right! And the mortality rate is inverted with the use of remestemcel-L.


    Wilba was being generous. You're very much an amateur at laughing at yourself, which is the foundation of true humourists.


    Sure, and let's not forget about how SI told us that the NIH were very "excited" about the prospect of funding another Covid-ARDS trial with Mesoblast....

    See you do this routine when smashed on one line of attack, you blithely dismiss this with 'sure'?

    As if the egregious 'errors' actually misrepresentations made by you are nothing!

    Sure! It's what can be mistaken for comedy.

    So let's not forget about how many egregious 'errors' or false claims you make, because when caught out, you're onto something else, shifting attention immediately.

    At least 2 serious ones and you're not pausing for breath.

    What a pity you can't leave the kiddies by the pool and dash down to Melbourne for the AGM. Like madam you're a bit shy about actually fronting up, you don't turn up for defamation trials either.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.